Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 29, 2026 07:55 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength

Vancouver, Canada, June 29, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development...
June 26, 2026 07:00 ET | Source: Marvel Biosciences Corp.

New Autism Research to be Presented at European Purine Scientific Meeting

New Autism Research to be Presented at European Purine Scientific Meeting by Marvel Biosciences Collaborators at iBrain Institute in Tours France
June 25, 2026 18:57 ET | Source: Shoals Technologies Group

Shoals Technologies Group Secures ITC Victory Upholding American Intellectual Property

Shoals Technologies Group Secures ITC Victory Upholding American Intellectual Property
June 25, 2026 08:00 ET | Source: Incannex Healthcare

Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea

MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company developing...
June 18, 2026 07:30 ET | Source: PMGC Holdings Inc.

NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets

NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets
June 16, 2026 09:00 ET | Source: Oncolytics Biotech, Inc.

Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044

Oncolytics Biotech announced that the USPTO has issued a new patent broadly protecting the proprietary manufacturing process for pelareorep into 2044.
June 16, 2026 02:30 ET | Source: Solvay S.A.

European Patent Office upholds Solvay’s Soda Ash recycling patent

European Patent Office upholds Solvay’s Soda Ash recycling patent Ruling secures critical milestone for Solvay in ongoing legal dispute with WE Soda Brussels, June 16, 2026 Solvay announces that...
June 10, 2026 07:47 ET | Source: Polyrizon Ltd.

Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Delivery Technology

Raanana, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative...
June 08, 2026 07:00 ET | Source: Marvel Biosciences Corp.

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204
June 02, 2026 08:00 ET | Source: Daxor Corporation

Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor

New Technology Expands Daxor’s Diagnostic Capabilities to Enable Continuous, Remote Tracking of Blood Volume Status Using Wearable Sensors, Enhancing Care for Heart Failure, Syncope, Anemia, and...